A synthetic progestogen
Related Products
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Medroxyprogesterone 17-acetate

Item No. 23664

Technical Information
Formal Name
17-(acetyloxy)-6α-methyl-pregn-4-ene-3,20-dione
CAS Number
71-58-9
Synonyms
  • NSC 21171
  • NSC 26386
  • U-8839
Molecular Formula
C24H34O4
Formula Weight
Purity
≥98%
A solid
Chloroform: Slightly SolubleMethanol: Slightly Soluble
SMILES
C[C@@]12[C@](CC[C@]2(OC(C)=O)C(C)=O)([H])[C@]3([H])C[C@H](C)C4=CC(CC[C@]4(C)[C@@]3([H])CC1)=O
InChi Code
InChI=1S/C24H34O4/c1-14-12-18-19(22(4)9-6-17(27)13-21(14)22)7-10-23(5)20(18)8-11-24(23,15(2)25)28-16(3)26/h13-14,18-20H,6-12H2,1-5H3/t14-,18+,19-,20-,22+,23-,24-/m0/s1
InChi Key
PSGAAPLEWMOORI-PEINSRQWSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Medroxyprogesterone 17-acetate is a synthetic progestogen.1,2,3 It prevents fertilization and increases the rate of transport of eggs from the fallopian tubes to the uterus in female ferrets when administered prior to ovulation.1 Medroxyprogesterone 17-acetate reversibly blocks ovulation in rats when injected on the last day of diestrus.2 It also has anti-androgenic activity in rats, decreasing plasma testosterone (Item Nos. 15645 | ISO60154) levels via induction of hepatic testosterone reductase activity.3 Medroxyprogesterone 17-acetate exhibits immunosuppressive effects in vitro and in vivo, inhibiting the production of IFN-γ by CD2/CD3/CD28-stimulated peripheral blood mononuclear cells (PBMCs) at concentrations ≥10 nM and extending the survival of rabbit skin allografts.4,5 Injectable formulations containing medroxyprogesterone 17-acetate have been used as contraceptives.6

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Chang, M.C. Effects of medroxyprogesterone acetate and of ethinyl oestradiol on the fertilization and transportation of ferret eggs. J. Reprod. Fertil. 13(1), 173-174 (1967).

    2. Dickmann, Z. Short- and long-term effects of a single injection of depo-medroxyprogesterone acetate (provera) on the vaginal smear, ovulation and mating in the rat. J. Reprod. Fertil. 32(3), 447-451 (1973).

    3. Albin, J., Vittek, J., Gordon, G.G., et alOn the mechanism of the anti-androgenic effect of medroxyprogesterone acetate. Endocrinology 93(2), (1973).

    4. Huijbregts, R.P., Michel, K.G., and Hel, Z. Effect of progestins on immunity: Medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs. Contraception 90(2), 123-129 (2014).

    5. Turcotte, J.G., Haines, R.F., Brody, G.L., et alImmunosuppression with medroxyprogesterone acetate. Transplantation 6(2), 248-260 (1968).

    6. Hofmeyr, G.J., Singata-Madliki, M., Lawrie, T.A., et alEffects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: A pragmatic randomized controlled trial. Reprod. Health 13, 42 (2016).